Notice of results

March 7, 2008 Group News
Tags
,

Cryo-Save Group NV, (AIM: CRYO, ‘the Company’), Europe’s largest adult stem cell storage bank, which was admitted to AIM on 6 November 2007, will be publishing its first Preliminary results for the year ended 31 December 2007 on Tuesday, 8 April 2008. The Company also expects to publish its Q1 Storage Figures at this time.

read more

Transaction in own shares – total voting rights

February 4, 2008 Group News

On Friday 1st February Cryo-Save Group N.V. (the “Company”) acquired 56,000 of its ordinary shares at an average price of 189 pence per ordinary share. The ordinary shares purchased will be held in treasury in order to satisfy the exercise of options granted by the Company under the Cryo-Save Group 2007 Option Scheme.

read more

Transaction in own shares – total voting rights

February 1, 2008 Group News

Cryo-Save Group N.V. (the “Company”) yesterday acquired 62,500 of its ordinary shares at an average price of 187 pence per ordinary share. The ordinary shares purchased yesterday will be held in treasury in order to satisfy the exercise of options granted by the Company under the Cryo-Save Group 2007 Option Scheme.

read more

Transaction in own shares

December 24, 2007 Group News
Tags

Cryo-Save Group N.V. (the “Company”), on Friday 21 December 2007, acquired 50,000 of its ordinary shares at an average price of 210 pence per ordinary share. The ordinary shares purchased will be held in treasury in order to satisfy the exercise of options granted by the Company under the Cryo-Save Group 2007 Option Scheme.

read more

Transaction in own shares

December 21, 2007 Group News
Tags

Cryo-Save Group N.V. (the “Company”) yesterday acquired 25,000 of its ordinary shares at an average price of 208 pence per ordinary share. The ordinary shares purchased yesterday will be held in treasury in order to satisfy the exercise of options granted by the Company under the Cryo-Save Group 2007 Option Scheme.

read more

Transaction in own shares

December 20, 2007 Group News
Tags

Cryo-Save Group N.V. (the “Company”) yesterday acquired 80,000 of its ordinary shares at an average price of 206 pence per ordinary share. The ordinary shares purchased yesterday will be held in treasury in order to satisfy the exercise of options granted by the Company under the Cryo-Save Group 2007 Option Scheme.

read more

Director/PDMR shareholding

December 10, 2007 Group News

Cryo-Save Group N.V. (“Cryo-Save” or “the Company”), Europe’s largest adult stem cell storage bank, announces that on 7 December 2007 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme. The Company granted 225,000 options to Directors of the Company (as detailed below) and 115,000 options to certain other employees of the Company all at an exercise price of 221p per share, being the price equal to the arithmetic average of the closing mid-market price over the five dealing days prior to the date of the grant.

read more

Page 45 of 46« First...102030...4243444546